IOMED INC
3, 2000-08-24
PHARMACEUTICAL PREPARATIONS
Previous: INDUS INTERNATIONAL INC, S-8, EX-23.1, 2000-08-24
Next: IOMED INC, 5, 2000-08-24





                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 3

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

________________________________________________________________________________
1.   Name and Address of Reporting Person*

Yanaki                                Jamal
--------------------------------------------------------------------------------
   (Last)                            (First)              (Middle)

                             385 North Wall Street
--------------------------------------------------------------------------------
                                    (Street)

Salt Lake City                       Utah                    84103
--------------------------------------------------------------------------------
   (City)                            (State)                (Zip)

________________________________________________________________________________
2.   Date of Event Requiring Statement (Month/Day/Year)

                                    02/09/00
________________________________________________________________________________
3.   IRS Identification Number of Reporting Person, if an Entity (Voluntary)


________________________________________________________________________________
4.   Issuer Name and Ticker or Trading Symbol

                               IOMED, INC. (IOX)
________________________________________________________________________________
5.   Relationship of Reporting Person to Issuer
     (Check all applicable)

     [_]  Director                             [_]  10% Owner
     [X]  Officer (give title below)           [_]  Other (specify below)
          General Manager, Clinical Systems
          ---------------------------------
________________________________________________________________________________
6.   If Amendment, Date of Original (Month/Day/Year)


________________________________________________________________________________
7.   Individual or Joint/Group Filing  (Check applicable line)

     [X]  Form Filed by One Reporting Person

     [_]  Form Filed by More than One Reporting Person

================================================================================
             Table I -- Non-Derivative Securities Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
                                                                 3. Ownership Form:
                                      2. Amount of Securities       Direct (D) or
1. Title of Security                     Beneficially Owned         Indirect (I)       4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                            (Instr. 4)                 (Instr. 5)            (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
   <S>                                   <C>                         <C>                  <C>


------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>

*    If the Form is filed by more than one  Reporting  Person,  see  Instruction
     5(b)(v).

Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.


                                                                          (Over)
(Form 3-07/99)

<PAGE>


FORM 3 (continued)

              Table II -- Derivative Securities Beneficially Owned
         (e.g., puts, calls, warrants, options, convertible securities)

================================================================================
<TABLE>
<CAPTION>
                                                                                                        5. Owner-
                                                    3. Title and Amount of Securities                      ship
                                                       Underlying Derivative Security                      Form of
                         2. Date Exercisable           (Instr. 4)                                          Derivative
                            and Expiration Date     ---------------------------------    4. Conver-        Security:
                            (Month/Day/Year)                               Amount           sion or        Direct      6. Nature of
                         ----------------------                            or               Exercise       (D) or         Indirect
                         Date       Expira-                                Number           Price of       Indirect       Beneficial
1. Title of Derivative   Exer-      tion                                   of               Derivative     (I)            Ownership
   Security (Instr. 4)   cisable    Date            Title                  Shares           Security       (Instr. 5)     (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
<S>                      <C>        <C>             <C>                    <C>           <C>            <C>            <C>

Stock Option             (1)      09/25/02           Common Stock           2,083            $4.80             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (1)      11/01/04           Common Stock           2,083            $4.80             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (1)      07/01/05           Common Stock           1,041            $4.80             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (2)      03/17/06           Common Stock           2,083            $6.72             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (3)      10/23/07           Common Stock           3,125            $8.88             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (4)      05/20/09           Common Stock          10,000            $2.31             D
------------------------------------------------------------------------------------------------------------------------------------
Stock Option             (5)      01/28/10           Common Stock          50,000            $3.875            D
------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Explanation of Responses:
(1)  Fully exercisable.
(2)  The  option  vests  in  equal  monthly  installments  of 34  common  shares
     beginning June 1, 1996. A total of 1,530 shares are fully exercisable as of
     February 9, 2000.
(3)  The  option  vests in  equal  monthly  installments  of 52  common  shares
     beginning  November 1, 1997. A total of 1,456 shares are fully  exercisable
     as of February 9, 2000.
(4)  The option  vests in equal  monthly  installments  of 2,000  common  shares
     beginning May 20, 2000. No shares have vested as of February 9, 2000.
(5)  The option vests in equal  monthly  installments  of 10,000  common  shares
     beginning January 28, 2001. No shares have vested as of February 9, 2000.


          /s/ Jamal Yanaki                                      8/22/00
---------------------------------------------            -----------------------
      **Signature of Reporting Person                             Date

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations.

     See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:  File three copies of this Form, one of which must be manually signed.
       If space provided is insufficient, see Instruction 6 for procedure.


                                                                          Page 2



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission